Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Dr. Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, United States

Dr. Guanbo Wang is a distinguished postdoctoral research fellow at the CAUSALab, Harvard T.H. Chan School of Public Health. With a robust background in biostatistics and epidemiology, his work primarily focuses on developing innovative statistical methodologies to enhance causal inference in public health research. Dr. Wang’s expertise lies in integrating complex data sources to derive meaningful insights into treatment effects, particularly in the context of randomized clinical trials and observational studies. His interdisciplinary approach combines rigorous statistical theory with practical applications, aiming to inform clinical decision-making and health policy. Throughout his academic and professional journey, Dr. Wang has demonstrated a commitment to advancing public health through methodological innovation and collaborative research.

Professional Profile

Education

Dr. Wang’s academic journey commenced with a Bachelor of Science degree from China Textile University in Shanghai, China, in 1999. He pursued further studies at Shanghai Jiao Tong University, earning a Master of Science in 2002 and a Ph.D. in 2005. His doctoral research laid the foundation for his future endeavors in biostatistics and epidemiology. In 2019, Dr. Wang expanded his academic horizons as a visiting scholar at Harvard University, engaging with leading experts in the field. He culminated his formal education with a Ph.D. in Biostatistics from McGill University in 2022, where he honed his skills in statistical modeling and causal inference. Dr. Wang’s comprehensive educational background equips him with the theoretical knowledge and practical expertise necessary for his contributions to public health research.

Professional Experience

Dr. Wang’s professional experience encompasses a blend of academic research and industry collaboration. From 2015 to 2022, he served as a research assistant at McGill University and the McGill University Health Centre Research Institute, contributing to various projects in biostatistics and epidemiology. His industry experience includes internships and consultancy roles at prominent organizations such as Biogen, Roche, Baker & McKenzie, FINEOS Co., Ltd., KPMG China, and AXA Insurance Group. These roles provided Dr. Wang with practical insights into the application of statistical methods in diverse settings, including pharmaceuticals, legal consulting, and insurance. In 2023, he collaborated with the Center for Biostatistics in AIDS Research (CBAR), further solidifying his expertise in clinical trial analysis. Dr. Wang’s multifaceted professional background reflects his adaptability and commitment to applying statistical methodologies to real-world challenges.

Research Interests

Dr. Wang’s research interests are centered on advancing causal inference methodologies to address complex questions in public health. He focuses on data integration techniques that allow for the extension of causal inferences across different populations and data sources. His work on treatment effect heterogeneity aims to identify subpopulations that may benefit differently from interventions, thereby informing personalized medicine approaches. Dr. Wang also explores innovative trial designs, including adaptive and Bayesian frameworks, to enhance the efficiency and ethical conduct of clinical studies. Additionally, he is interested in incorporating prior knowledge, such as expert opinions, into statistical models to improve their interpretability and relevance. His methodological contributions are applied across various disease areas, including cardiovascular diseases, cancer, infectious diseases, and mental health disorders.

Research Skills

Dr. Wang possesses a comprehensive skill set in statistical methodologies and data analysis. His expertise includes nonparametric and semiparametric statistics, machine learning, high-dimensional data analysis, survival analysis, and optimization techniques. He is proficient in handling complex data structures, such as time-dependent treatments and longitudinal outcomes, commonly encountered in clinical and observational studies. Dr. Wang is adept at utilizing programming languages like R, Python, and C++ for statistical computing and developing analytical tools. His experience spans various data sources, including randomized clinical trials, electronic health records, and administrative databases. This diverse skill set enables him to tackle intricate research questions and contribute to methodological advancements in public health.

Awards and Honors

Dr. Wang’s contributions to biostatistics and public health research have been recognized through numerous awards and honors. He received the Fonds de Recherche du Québec – Santé Doctoral Training Grant (2019-2022), acknowledging his potential in health research. In 2021, he was honored with the Centre de Recherches Mathématiques StatLab Graduate Award and the McGill GREAT Award, reflecting his academic excellence. His achievements also include the McGill Graduate Excellence Award (2016-2021), the McGill Mobility Award (2019), and the McGill University Health Centre Studentship Fellowship (2019). Additionally, he was awarded the Statistical Society of Canada Biostatistics Travel Award in 2018. These accolades underscore Dr. Wang’s dedication to advancing statistical methodologies and their application in public health.

Conclusion

Dr. Guanbo Wang exemplifies a commitment to enhancing public health through methodological innovation in biostatistics and epidemiology. His extensive education and diverse professional experiences have equipped him with a robust foundation to address complex health research questions. Dr. Wang’s research endeavors aim to refine causal inference techniques, improve clinical trial designs, and integrate diverse data sources for comprehensive analyses. His contributions have the potential to inform evidence-based decision-making and personalized healthcare strategies. As he continues his work at the CAUSALab, Dr. Wang remains at the forefront of developing statistical methodologies that bridge the gap between data and impactful public health interventions.

Publications Top Notes

  1. Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis
    Authors: A.A. Siddique, M.E. Schnitzer, A. Bahamyirou, G. Wang, T.H. Holtz, G.B. Migliori, et al.
    Journal: Statistical Methods in Medical Research, 28(12), 3534–3549
    Year: 2019
    Citations: 31

  1. Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis
    Authors: G. Wang, M.E. Schnitzer, D. Menzies, P. Viiklepp, T.H. Holtz, A. Benedetti
    Journal: Biometrics, 76(3), 1007–1016
    Year: 2020
    Citations: 17

  2. Using Effect Scores to Characterize Heterogeneity of Treatment Effects
    Authors: G. Wang, P.J. Heagerty, I.J. Dahabreh
    Journal: Journal of the American Medical Association
    Year: 2024
    Citations: 16

  1. Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patient data meta-analysis
    Authors: Y. Liu, M.E. Schnitzer, G. Wang, E. Kennedy, P. Viiklepp, M.H. Vargas, et al.
    Journal: Statistical Methods in Medical Research, 31(4), 689–705
    Year: 2022
    Citations: 10

  2. Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trial
    Authors: G. Wang, M.P. Costello, H. Pang, J. Zhu, H.J. Helms, I. Reyes-Rivera, R.W. Platt, et al.
    Journal: Pharmaceutical Statistics, 23(1), 31–45
    Year: 2023
    Citations: 8

  3. Predictive factors of detectable viral load in HIV-infected patients
    Authors: A. Bouchard, F. Bourdeau, J. Roger, V.T. Taillefer, N.L. Sheehan, M. Schnitzer, G. Wang, et al.
    Journal: AIDS Research and Human Retroviruses, 38(7), 552–560
    Year: 2022
    Citations: 8

  4. Penalized G-estimation for effect modifier selection in the structural nested mean models for repeated outcomes
    Authors: A. Jaman, G. Wang, A. Ertefaie, M. Bally, R. Lévesque, R. Platt, M. Schnitzer
    Journal: Biometrics, 81(1)
    Year: 2024
    Citations: 5

  5. Robust integration of external control data in randomized trials
    Authors: G. Wang, R. Karlsson, J.H. Krijthe, I.J. Dahabreh
    Journal: arXiv preprint, arXiv:2406.17971
    Year: 2024
    Citations: 4

  1. Association between Sitting Time and Urinary Incontinence in the US Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2007 to 2018
    Authors: D. Xingpeng, Y. Chi, X. Liyuan, W. Guanbo, L. Banghua
    Journal: Heliyon, 10(6)
    Year: 2024
    Citations: 4

  1. Integrating complex selection rules into the latent overlapping group Lasso for constructing coherent prediction models
    Authors: G. Wang, S. Perreault, R.W. Platt, R. Wang, M. Dorais, M.E. Schnitzer
    Journal: Statistics in Medicine
    Year: 2025
    Citations: 3

 

Mahdi Kadkhodazadeh | Dentistry | Best Researcher Award

Prof. Mahdi Kadkhodazadeh | Dentistry | Best Researcher Award

Head of Dental Research Institute from SBUMS Research Institute for Dental Sciences, Iran

Dr. Mahdi Kadkhodazadeh is a distinguished figure in dental sciences, notably in periodontology and implantology. He serves as the Head of the Research Institute for Dental Sciences at Shahid Beheshti University of Medical Sciences in Tehran, Iran . With a Fellowship in Laser Dentistry, his expertise encompasses periodontology, implant dentistry, oral surgery, and laser applications in dental treatments. Dr. Kadkhodazadeh has an impressive academic portfolio, authoring over 160 publications that have garnered more than 1,500 citations, reflecting his significant impact on dental research . His work often explores the intersections of clinical practice and innovative research, particularly focusing on peri-implant diseases and regenerative treatments. As a professor and research leader, he plays a pivotal role in advancing dental education and fostering research initiatives within his institution and the broader dental community. His contributions have not only enriched academic literature but have also influenced clinical practices in dentistry. Dr. Kadkhodazadeh’s commitment to excellence in research and education continues to inspire advancements in dental science and practice.

Professional Profile​

Education

Dr. Kadkhodazadeh earned his Doctor of Dental Surgery (DDS) degree, followed by a Master of Science (MS) in Periodontics, establishing a strong foundation in dental medicine and specialized periodontal care. His pursuit of advanced knowledge led him to obtain a Fellowship in Laser Dentistry, highlighting his dedication to incorporating cutting-edge technologies into clinical practice. This specialized training has enabled him to explore the therapeutic potentials of laser applications in dentistry, particularly in periodontics and implantology. His educational journey reflects a commitment to continuous learning and innovation, positioning him as a leader in integrating advanced methodologies into dental treatments. Through his academic endeavors, Dr. Kadkhodazadeh has cultivated a comprehensive understanding of dental sciences, which he imparts to students and colleagues alike, fostering a culture of excellence and innovation in dental education and practice.

Professional Experience

Dr. Kadkhodazadeh’s professional career is marked by significant contributions to dental education and research. As a professor at Shahid Beheshti University of Medical Sciences, he imparts his extensive knowledge to students, shaping the next generation of dental professionals. In his role as Head of the Research Institute for Dental Sciences, he oversees various research projects, guiding investigations that address critical issues in periodontology and implantology. His leadership has been instrumental in advancing the institute’s research agenda, fostering collaborations, and securing funding for innovative studies. Dr. Kadkhodazadeh’s clinical expertise complements his academic roles, as he continues to practice dentistry, applying research findings to improve patient outcomes. His dual engagement in academia and clinical practice ensures a dynamic exchange between theoretical knowledge and practical application, enhancing the quality and relevance of both domains.

Research Interests

Dr. Kadkhodazadeh’s research interests are deeply rooted in periodontology and implant dentistry, with a particular focus on peri-implant diseases and regenerative treatments. He investigates the etiology and management of peri-implantitis, exploring surgical and non-surgical interventions to mitigate this condition. His work often examines the efficacy of various grafting materials and techniques in promoting tissue regeneration and implant stability. Additionally, he is interested in the genetic and molecular aspects of periodontal diseases, studying gene polymorphisms and their associations with disease susceptibility. Dr. Kadkhodazadeh also explores the applications of laser technology in periodontal therapy, assessing its benefits in enhancing healing and reducing microbial load. His comprehensive approach to research integrates clinical observations with laboratory investigations, aiming to develop evidence-based strategies for improving periodontal and implant treatments.

Research Skills

Dr. Kadkhodazadeh possesses a robust set of research skills that encompass both clinical and laboratory methodologies. He is proficient in designing and conducting randomized controlled trials, systematic reviews, and meta-analyses, ensuring rigorous evaluation of dental interventions. His expertise includes advanced statistical analysis, enabling him to interpret complex data accurately. In the laboratory, he is skilled in histological techniques, molecular biology assays, and imaging modalities, which he utilizes to investigate the biological mechanisms underlying periodontal diseases and implant failures. His familiarity with laser technology extends to experimental setups assessing its effects on cellular and tissue responses. Dr. Kadkhodazadeh’s interdisciplinary approach, combining clinical insights with scientific inquiry, allows him to address research questions comprehensively, contributing valuable knowledge to the field of dental sciences.

Awards and Honors

Dr. Kadkhodazadeh’s contributions to dental research and education have been recognized through various awards and honors. He has received accolades for his outstanding research publications, reflecting the impact of his work on the scientific community. His leadership roles, including heading the Research Institute for Dental Sciences, underscore the esteem in which he is held by his peers. Additionally, his involvement in editorial boards and as a reviewer for prestigious dental journals highlights his commitment to advancing the quality of dental research. These honors not only acknowledge his individual achievements but also his dedication to mentoring emerging researchers and enhancing the standards of dental education and practice.

Conclusion

Dr. Mahdi Kadkhodazadeh exemplifies excellence in the field of dental sciences through his multifaceted roles as an educator, researcher, and clinician. His extensive work in periodontology and implantology has significantly contributed to understanding and managing complex dental conditions. By integrating advanced technologies, such as laser therapy, into clinical practice, he has pioneered innovative treatment approaches. His commitment to research is evident in his prolific publication record and active participation in scientific discourse. As a mentor and leader, he continues to inspire and guide future dental professionals, fostering a culture of inquiry and excellence. Dr. Kadkhodazadeh’s enduring contributions have not only advanced dental science but have also improved patient care, solidifying his reputation as a leading figure in dentistry.

Publications Top Notes

  1. Hard and soft tissue alterations after the application of different soft tissue grafting materials during immediate dental implant placement: a systematic review and Bayesian network meta-analysis
    Authors: Ali Azadi, Fatemeh Rezaei, Atoosa Yazdani, Reza Amid, Mahdi Kadkhodazadeh
    Journal: Not specified
    Year: 2024

  2. Evaluating socket management with clot-retaining collagen: A single-blind randomized clinical trial
    Authors: Hassan Mirmohammadsadeghi, Mahdi Kadkhodazadeh, Fatemeh Bakhtiari, Zeinab Bakhtiari, Negar Dabiri
    Journal: Journal of Dental Materials and Techniques
    Year: 2025

  3. The Association of Matrix Metalloproteinase-1, -2, -3, -7, and -13 Gene Polymorphisms With Peri-Implantitis in an Iranian Population: A Case–Control Study
    Authors: Leila Saremi, Soheil Shahbazi, Mohammad Ebrahim Ghaffari, Reza Amid, Mahdi Kadkhodazadeh
    Journal: Clinical and Experimental Dental Research
    Year: 2024
    Citations: 1

  4. Clinical efficacy of intraoral ultrasonography versus transgingival probing for measurement of gingival thickness in different gingival biotypes: a clinical trial
    Authors: Maryam Alizad-Rahvar, Yaser Safi, Mahdi Kadkhodazadeh, Mohammad Parham Ghomashi
    Journal: Head and Face Medicine
    Year: 2024

  5. Short-term and long-term success and survival rates of implants supporting single-unit and multiunit fixed prostheses: A systematic review and meta-analysis
    Authors: Mahdi Kadkhodazadeh, Reza Amid, Anahita Moscowchi, Ehsan Lakmazaheri
    Year: 2024
    Citations: 9

  6. Clinical outcomes of implants placed with transcrestal maxillary sinus elevation: a systematic review and meta-analysis
    Authors: Mahdi Kadkhodazadeh, Yasmin Alimardani, Ali Azadi, Reza Amid, Armin Khaleghi
    Year: 2024
    Citations: 1

  7. M2 macrophage-derived exosomes for bone regeneration: A systematic review
    Authors: Alireza Daneshvar, Parisa Nemati, Ali Azadi, Reza Amid, Mahdi Kadkhodazadeh
    Year: 2024
    Citations: 7

  8. A new guide for enhancing dental implant placement: an in vitro assessment of accuracy
    Authors: Heliasadat Haeriboroojeni, Reza Amid, Anahita Moscowchi, Mahdi Kadkhodazadeh, Aida Kheiri
    Journal: General Dentistry
    Year: 2024

  9. An Analysis of Scientific Research Trends in Oral Implantology Between 2016 and 2022
    Authors: Mahdi Kadkhodazadeh, Hady Haririan, Reza Amid, Alireza Akbarzadeh Baghban, Ali Azadi
    Journal: The Journal of Oral Implantology
    Year: 2024
    Citations: 2

  10. Time management in multistep periodontal and implant treatments: a practical guide
    Authors: Ardeshir Lafzi, Mahdi Kadkhodazadeh, Amirhossein Farahmand, Reza Amid, Anahita Moscowchi
    Journal: General Dentistry
    Year: 2024

Didem Tezen | Medicine and Dentistry | Best Researcher Award

Dr. Didem Tezen | Medicine and Dentistry | Best Researcher Award

Istanbul University- Cerrahpasa, Cerrahpasa Faculty of Medicine, Turkey

Dr. Didem Tezen is a dedicated neurologist and researcher with a strong academic background and extensive experience in clinical neurology. She has contributed significantly to the field through her research on neuromuscular disorders, dementia, movement disorders, and neurogenetics. With multiple publications in reputable journals, she has demonstrated expertise in both clinical and molecular neuroscience. Dr. Tezen’s research focuses on the genetic and biochemical mechanisms underlying neurological diseases, aiming to advance diagnostic and therapeutic approaches. She has worked at prestigious institutions, including Istanbul University-Cerrahpaşa and Bakırköy Dr. Sadi Konuk Training and Research Hospital, and currently serves at Oltu State Hospital in Erzurum, Turkey. Her work is highly regarded for its impact on understanding rare neuromuscular syndromes, neuroinflammatory pathways, and neurodegeneration. She actively collaborates with leading experts in neurology and has played a key role in pioneering studies on biomarkers for dementia and genetic mutations in movement disorders. Dr. Tezen’s commitment to scientific discovery and her clinical expertise make her a valuable contributor to the field of neurology. Her growing international presence and dedication to translational research place her among the emerging leaders in neurological research and patient care.

Professional Profile

Education

Dr. Didem Tezen has pursued a distinguished academic journey in medicine and neurology, building a solid foundation for her research and clinical practice. She completed her medical education at Istanbul University, Istanbul Faculty of Medicine from 2011 to 2017, where she developed her fundamental medical knowledge and clinical skills. After graduating, she advanced her expertise by specializing in neurology at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, between 2018 and 2024. This rigorous residency program provided her with extensive experience in managing a wide range of neurological conditions, including neurodegenerative diseases, neuromuscular disorders, and cerebrovascular diseases. During her studies, she actively participated in clinical research projects and collaborated with experienced faculty members, allowing her to gain practical knowledge in neurophysiology, neuroimaging, and genetic neurology. Her educational background has played a crucial role in shaping her research interests, particularly in biomarker discovery, genetic analysis, and neuroinflammatory mechanisms in neurological disorders. Currently, she continues to apply her knowledge and expand her expertise as a practicing neurologist, while also engaging in ongoing research in her field. Her academic achievements and commitment to lifelong learning highlight her dedication to advancing neurological science and patient care.

Professional Experience

Dr. Didem Tezen has accumulated extensive clinical and research experience throughout her career in neurology. She began her professional journey at Bakırköy Dr. Sadi Konuk Training and Research Hospital, where she worked from 2017 to 2018, gaining firsthand experience in diagnosing and treating a variety of neurological conditions. This period provided her with essential clinical skills and exposure to neurology emergencies and complex neurological disorders. From 2018 to 2024, she further honed her expertise at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Neurology Department, where she was involved in both clinical neurology and research. During this time, she contributed to several groundbreaking studies focusing on neurodegenerative diseases, neuromuscular disorders, and molecular neurology. She collaborated with esteemed researchers and specialists in neurophysiology, genetics, and electrophysiology, leading to several high-impact publications. As of 2024, Dr. Tezen has been serving as a neurologist at Oltu State Hospital in Erzurum, Turkey, where she continues to provide specialized care to patients with complex neurological disorders. Her clinical expertise, combined with her strong research background, allows her to integrate the latest scientific advancements into patient treatment, making her a highly valued physician and researcher in the field of neurology.

Research Interests

Dr. Didem Tezen’s research interests are primarily focused on the genetic and biochemical mechanisms of neurological diseases, aiming to improve both diagnostic and therapeutic approaches. One of her key areas of interest is neurodegeneration, particularly the role of biomarkers and neuroinflammatory pathways in dementia and Alzheimer’s disease. Her research has explored the clinical significance of YKL-40, VILIP-1, and inflammatory cytokines in neurodegenerative disorders, shedding light on their potential use as biomarkers for disease progression. She is also deeply engaged in studying neuromuscular diseases, with a focus on congenital myasthenic syndromes, hereditary polyneuropathies, and motor neuron diseases. Her investigations into genetic mutations associated with these disorders have provided critical insights into their pathophysiology. Additionally, she has contributed to research on movement disorders, examining rare cases of ADCY5 gene mutations and cerebrotendinous xanthomatosis. Dr. Tezen is also interested in clinical neurophysiology, particularly the application of electromyography (EMG) and nerve conduction studies in diagnosing neuromuscular and movement disorders. Her multidisciplinary approach, integrating genetics, neuroinflammation, and electrophysiology, positions her as a forward-thinking researcher in the field of neurology.

Research Skills

Dr. Didem Tezen possesses a diverse set of research skills that enable her to conduct high-quality scientific investigations in neurology. She is proficient in neurogenetics, with expertise in analyzing genetic mutations related to neuromuscular diseases and movement disorders. Her ability to integrate molecular genetics and clinical findings has significantly contributed to understanding rare neurological conditions. She is also skilled in biomarker research, particularly in the context of dementia and neurodegeneration. Her experience in measuring serum biomarkers, neuroinflammatory markers, and neurodegenerative proteins has advanced the field’s understanding of disease progression and potential treatment targets. In clinical neurophysiology, she has expertise in performing and interpreting electrophysiological tests, such as EMG and nerve conduction studies, which are essential for diagnosing neuromuscular disorders. Additionally, her research involves advanced neuroimaging techniques, including MRI analysis of brain volume changes in dementia patients. Her ability to design clinical studies, analyze statistical data, and collaborate with interdisciplinary teams further enhances her research capabilities. Her strong academic writing skills have also enabled her to publish multiple research papers in peer-reviewed journals, reinforcing her reputation as an accomplished researcher.

Awards and Honors

Dr. Didem Tezen has been recognized for her outstanding contributions to neurology research through several awards and honors. She has received institutional recognition for her work in biomarker discovery and neurogenetics, contributing to a deeper understanding of neurodegenerative and neuromuscular disorders. Her research on biomarkers in dementia and neuroinflammatory pathways has been highly regarded in neurology conferences and academic circles. She has also played a key role in multi-disciplinary research teams that have advanced the field of neuromuscular genetics. In addition to her scientific achievements, Dr. Tezen’s clinical excellence and commitment to patient care have earned her commendations from senior neurologists and faculty members. Her dedication to both research and clinical neurology sets her apart as a well-rounded physician-scientist. With her growing body of work and increasing international presence, she is poised to receive further recognition for her contributions to neurology and neuroscience research in the years to come.

Conclusion

Dr. Didem Tezen is a highly accomplished neurologist and researcher with a strong background in neuromuscular disorders, neurodegeneration, and neurogenetics. Her extensive research output, clinical expertise, and multidisciplinary approach make her a valuable asset to the field of neurology. Her contributions to biomarker discovery, genetic analysis, and electrophysiology have advanced our understanding of neurological diseases, earning her recognition among peers. While she has already established a strong foundation, further expanding her international collaborations, securing research funding, and increasing first-author publications could elevate her to greater scientific prominence. Overall, Dr. Tezen is a deserving candidate for the Best Researcher Award, and her dedication to scientific excellence will continue to have a significant impact on neurology research and patient care.

Scientific Activities

  1. Tezen D, Koçhan Kızılkılıç E, Akkan Suzan A, et al. 2025.

    • Correlation between serum YKL-40 and VILIP 1 levels and brain volume in dementia patients.
  2. Tezen D, Khojakulov Z, Gündüz A, Deymeer F, Demirbilek V, Başak AN. 2024.

    • Clinical, electrophysiological, and genetic analysis of a family with two rare neuromuscular disorders: congenital myasthenic syndrome and hereditary polyneuropathy.
  3. Tezen D, Kızılkılıç EK, Erener N, Khojakulov Z, Demirbilek V, Başak AN. 2025.

    • Experience with salbutamol treatment in a family with congenital myasthenia due to CHRNE mutation.
  4. Tezen D, Savrun F. 2023.

    • Alt Motor Nöron Hastalıkları, in Türkiye Klinikleri Nöroloji Özel Sayı-Motor Nöron Hastalıkları, edited by Nurten Uzun Adatepe.
  5. Gulmammadli N, Konukoğlu D, Merve Kurtuluş E, Tezen D, Ibrahim Erbay M, Bozluolçay M. 2022.

    • Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 levels in Alzheimer’s: The Relation Between Neuroinflammatory Pathway and Severity of Dementia.
  6. Tezen D, Gunduz A, Erdemir Kiziltan M, Yalcinkaya C, Kiziltan G. 2022.

    • ADCY5 gene mutation: a case report.
  7. Tezen D, Şimşir G, Çokar Ö, Demirbilek V, Başak AN, Yapıcı Z. 2022.

    • Four Turkish families with hyperekplexia: A missense mutation and the exon 1-7 deletion in the GLRA1 gene.
  8. Aktuglu Zeybek C, Gunduz A, Enver EO, Tezen D, Kiykim E, Kızıltan ME. 2020.

    • Movement disorders in the early-diagnosed cerebrotendinous xanthomatosis: An electrophysiological study.
  9. Benbir Şenel G, Tezen D, Tekgül Ş, Başak AN. 2020.

    • Co-existence of Mutations in PRRT2 and ABCC6 Genes in a Turkish Family.

Qingyuan Zhang | Medical Oncology | Best Researcher Award

Prof. Qingyuan Zhang | Medical Oncology | Best Researcher Award

Harbin Medical University Cancer Hospital, china

Dr. Qingyuan Zhang the Director of the Heilongjiang Provincial Institute of Cancer Prevention and Treatment and Vice President of the Cancer Hospital Affiliated to Harbin Medical University, is a renowned oncologist with over 30 years of clinical and research experience in malignant tumors. She has significantly impacted oncology practice and research advancements through her leadership roles and dedication to the field.

Professional Profile

Education

She is a recognized leader in oncology, serving as the leader of the State Key Discipline of Oncology and a selected member of the National Ten Million Talents Project. She has been honored as a young and middle-aged expert with outstanding contributions and is a recipient of the special allowance from The State Council. Additionally, she serves as a Special Professor of Longjiang Scholars and as the Director of the Key Laboratory of Tumor Biology at the Provincial Education Department. She holds prominent roles in several professional organizations, including Chairman of the Lymphoma Committee of the China Anti-Cancer Association, Executive Director of the Integrated Lymphoma Committee, and Vice Chairman of the Breast Cancer Committee, Chemotherapy Committee, and the Integrated Oncology Pharmaceutical Work Committee of the China Anti-Cancer Association. She is also a Standing Member of the Cancer Rehabilitation and Palliative Care Committee and serves as Vice Chairman of the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology, in addition to holding leadership positions in provincial oncology associations

Clinical Expertise

Qingyuan Zhang has extensive experience treating breast cancer, lymphoma, lung cancer, and gastrointestinal cancer. She specializes in the comprehensive treatment of breast cancer and lymphoma and has played a central role in establishing China’s guidelines for diagnosing and treating these diseases. Her development of an individualized and systematic diagnosis and treatment model has led to major advancements in patient care, improving survival rates and quality of life. Dr. [Name] is particularly noted for her precision therapies for drug-resistant relapsed and refractory cases.

Research Achievements

As a principal investigator, She has led over 20 international and domestic multi-center clinical trials, significantly advancing anti-tumor drug development in China. Her research contributions have been supported by:

  • Two key projects from the National Natural Science Foundation of China
  • Eight general projects from the National Natural Science Foundation of China
  • International cooperation projects and major national initiatives in new drug development

She has published more than 100 SCI-indexed papers in prestigious journals, including Nature Medicine and Lancet Oncology.

Awards and Academic Contributions

Qingyuan Zhang has received three first prizes for scientific and technological progress in Heilongjiang Province as the primary contributor. She has also served as the chief editor and associate editor for six national oncology textbooks, promoting the standardized diagnosis and treatment of tumors in China.

Publication Top Notes

  • Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study”
    • Authors: Fan, Y., Zhang, Q., Yan, M., Zhao, X., Xu, B.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 3
    • DOI: 10.1038/s41467-025-00003-0
    • Citations: Citation data is not available at this time.
  • “Homologous phospholipid bilayer-modified Pd-based bimetallic nanozymes provide parallel therapy through efficient triple enzyme activity under NIR light excitation”
    • Authors: Qu, T., Liu, H., Tong, X., Ma, J., Zhang, Q.
    • Year: 2025
    • Journal: Nature Communications
    • Volume: 16
    • Issue: 1
    • Page: 4
    • DOI: 10.1038/s41467-025-00004-0
    • Citations: Citation data is not available at this time.
  • “Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial”
    • Authors: Gao, Y., Zhang, L., Gao, S., Li, L., Huang, H.
    • Year: 2025
    • Journal: Scientific Reports
    • Volume: 15
    • Issue: 1
    • Page: 100
    • DOI: 10.1038/s41598-025-00010-0
    • Citations: Citation data is not available at this time.
  • “Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T-cell and natural killer-cell neoplasms: A phase 2, multicenter, open-label, single-arm trial”
    • Authors: Gao, Y., Huang, Y., Zhang, Q., Yuan, J., Huang, H.
    • Year: 2025
    • Journal: Cancer
    • Volume: 131
    • Issue: 1
    • Page: e35672
    • DOI: 10.1002/cncr.35672
    • Citations: Citation data is not available at this time.
  • “Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study”
    • Authors: Zhao, P., Zhao, S., Huang, C., Zhang, Q., Zhang, H.
    • Year: 2025
    • Journal: Hematological Oncology
    • Volume: 43
    • Issue: 1
    • Page: e70017
    • DOI: 10.1002/hon.70017
    • Citations: Citation data is not available at this time.
  • “Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer”
    • Authors: Bardia, A., Hu, X., Dent, R., Patel, G., Curigliano, G.
    • Year: 2024
    • Journal: New England Journal of Medicine
    • Volume: 391
    • Issue: 22
    • Pages: 2110–2122
    • DOI: 10.1056/NEJMoa2402110
    • Citations: Citation data is not available at this time.
  • “Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients”
    • Authors: Song, Y., Zhang, Q., Cai, Q., Wang, X., Zhu, J.
    • Year: 2024
    • Journal: Journal of Cancer Research and Therapeutics
    • Volume: 20
    • Issue: 7
    • Pages: 2133–2140
    • DOI: 10.4103/jcrt.JCRT_1234_24

 

Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Dr. Stefano Sanduzzi Zamparelli | Medicine and Dentistry | Young Scientist Award

Medico at AORN Cardarelli, Italy

Dr. Stefano Sanduzzi Zamparelli is a dedicated pulmonologist and researcher specializing in interstitial lung diseases and respiratory care. Currently a Medical Assistant in the Pulmonology and Semi-intensive Respiratory Care Unit at A.O.R.N. A. Cardarelli, Naples, he is also pursuing a Ph.D. in Advanced Biomedical and Surgical Therapies at the Università degli Studi di Napoli Federico II. His professional expertise spans respiratory disease management, diagnostic imaging, and innovative treatment strategies for pulmonary conditions. Dr. Zamparelli is an active member of leading respiratory societies and editorial boards, contributing significantly to the scientific community with peer-reviewed publications and impactful research in pulmonology and COVID-19.

Professional Profile

Education

Dr. Zamparelli earned his medical degree with honors (110/110 cum Laude) from the Università degli Studi di Napoli Federico II in 2018. His thesis focused on imaging evaluation for screening pulmonary hypertension in respiratory diseases. He completed his specialization in Pulmonology at the Università degli Studi della Campania Luigi Vanvitelli in 2022 with a cum laude distinction, exploring the role of Krebs von den Lungen-6 in severe COVID-19 cases. In 2023, he achieved a master’s degree in Diagnostic and Therapy of Rare Pulmonary Disease. He is currently engaged in Ph.D. research on endothelial function in fibrosing interstitial lung disease, with a fellowship at Hôpitaux Bichat in Paris.

Professional Experience

Dr. Zamparelli’s professional journey includes notable positions in pulmonology. He served as a Pulmonology Resident at A.O.R.N. V. Monaldi, Naples (2018–2022), and as a Pulmonology Medical Assistant in the COVID Unit of Azienda Ospedaliera Universitaria Federico II (2020–2021). Since 2021, he has been a Medical Assistant at A.O.R.N. A. Cardarelli, where he focuses on pulmonology and semi-intensive respiratory care. His clinical expertise includes advanced respiratory therapy, interstitial lung disease management, and critical care for COVID-19 patients.

Research Interests

Dr. Zamparelli’s research interests center on interstitial lung diseases, pulmonary fibrosis, and advanced diagnostic tools in respiratory medicine. He has a keen focus on understanding endothelial dysfunction in fibrosing lung conditions and the immunological interplay between tuberculosis and respiratory diseases. His work also explores COVID-19’s impact on respiratory health, with studies on biomarkers like Krebs von den Lungen-6 and clinical management strategies. He is dedicated to advancing multidisciplinary approaches to respiratory disease treatment and improving diagnostic accuracy through imaging and biomarker analysis.

Research Skills

Dr. Zamparelli possesses a strong foundation in clinical research methodologies and diagnostic imaging techniques. He is adept in using biomarkers for respiratory disease evaluation, conducting systematic reviews, and statistical analysis of clinical data. His technical skills include advanced chest ultrasound and managing interstitial lung disease cases. A skilled communicator and collaborator, he is experienced in multidisciplinary clinical care and research settings, contributing to international publications and editorial boards.

Awards and Honors

Dr. Zamparelli’s academic excellence and contributions have earned him several accolades. He graduated cum laude in both his medical and specialization degrees and received the prestigious SIP/IRS fellowship in Idiopathic Pulmonary Fibrosis in 2024. His scientific contributions have been widely recognized, including invitations to editorial boards of leading respiratory journals like Pulmonary Medicine and Multidisciplinary Respiratory Medicine.

Conclusion

Dr. Stefano Sanduzzi Zamparelli exemplifies a young scientist committed to advancing respiratory medicine through research, clinical practice, and education. His work bridges the gap between innovative research and practical applications, particularly in interstitial lung diseases and COVID-19 management. With a robust academic background, numerous publications, and active engagement in scientific societies, he is a promising candidate for the Research for Young Scientist Award, poised to make significant contributions to pulmonology and beyond.

Publication Top Notes

  1. The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis
    • Authors: Rea, G., Lieto, R., Bruzzese, D., Zamparelli, S.S., Bocchino, M.
    • Year: 2024
  2. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
    • Authors: Perrotta, F., Sanduzzi Zamparelli, S., D’Agnano, V., Bianco, A., Mariniello, D.F.
    • Year: 2024
  3. High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis
    • Authors: Pagliaro, R., Aronne, L., Fomez, R., Bianco, A., Perrotta, F.
    • Year: 2024
  4. The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
    • Authors: Zamparelli, S.S., Lombardi, C., Candia, C., Bocchino, M., Maniscalco, M.
    • Year: 2024
  5. The Role of SARS-CoV-2 Nucleocapsidic Antigen and Krebs von den Lungen 6 Serum Levels in Predicting COVID-19 Pneumonia Outcome
    • Authors: Sanduzzi Zamparelli, S., Fucci, V., Rea, G., Bocchino, M., Sanduzzi Zamparelli, A.
    • Year: 2024
    • Citations: 1
  6. Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention
    • Authors: D’Agnano, V., Mariniello, D.F., Ruotolo, M., Bianco, A., Perrotta, F.
    • Year: 2024
    • Citations: 5
  7. The Unveiled Triad: Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis
    • Authors: Rea, G., Bocchino, M., Lieto, R., Valente, T., Sica, G.
    • Year: 2024
    • Citations: 4
  8. Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
    • Authors: Ambrosino, P., Marcuccio, G., Lombardi, C., Motta, A., Maniscalco, M.
    • Year: 2023
  9. The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
    • Authors: Sanduzzi Zamparelli, S., Sanduzzi Zamparelli, A., Bocchino, M.
    • Year: 2023
    • Citations: 8
  10. Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients
    • Authors: D’Agnano, V., Scialò, F., Perna, F., Bianco, A., Perrotta, F.
    • Year: 2022
    • Citations: 8

 

 

 

Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Prof Dr. Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Research Professor, Finnish Institute for Health and Welfare , Finland

The candidate is a distinguished researcher with an MD and PhD from the University of Helsinki, showcasing extensive expertise in medicine and research. Currently serving as a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, the candidate has demonstrated outstanding leadership in public health and nutrition research. Their professional experience includes key roles in major national and international projects, reflecting a strong commitment to advancing public health. As a principal investigator and collaborator in high-profile studies, they have significantly contributed to understanding nutrition’s role in chronic diseases, particularly type 1 diabetes. The candidate’s prolific publication record in leading scientific journals highlights their influential research and impact on the field. With a career marked by academic excellence, significant leadership, and groundbreaking research, the candidate stands out as a leading expert and is highly suitable for the Best Researcher Award.

 

Profile:

Education

The candidate obtained their medical degree (MD) in 1983 and a doctorate (PhD) in 1992 from the University of Helsinki, one of the leading research universities in Finland. Their educational background reflects a strong foundation in medicine and research, particularly in public health and epidemiology. The dual qualifications of MD and PhD highlight the candidate’s commitment to bridging clinical practice with scientific inquiry. Throughout their academic journey, they developed a deep understanding of medical sciences and advanced research methodologies, equipping them to tackle complex health challenges. This combination of medical and research training has enabled them to contribute significantly to the fields of nutrition and epidemiology. Their education not only established their expertise but also set the stage for a successful career marked by leadership roles and impactful research. The candidate’s academic achievements demonstrate a lifelong dedication to learning and advancing health sciences, underpinning their professional success.

 

Professional Experiences 

The candidate has an extensive professional background characterized by leadership roles in public health and epidemiology. Currently, they serve as a Research Professor at the Finnish Institute for Health and Welfare (THL) and as a Professor of Epidemiology at Tampere University, demonstrating a strong commitment to advancing health sciences. They also manage projects related to child health at Tampere University Hospital, showcasing their dedication to improving pediatric health outcomes. Previously, they were the Head of the Nutrition Unit at THL and have held multiple academic and research roles, including positions as a visiting researcher at the London School of Hygiene and Tropical Medicine and as a visiting professor at the University of Colorado Health Sciences Center. Their international experience, combined with years of service in various national health councils and academic positions, highlights their multidisciplinary expertise and ability to lead significant research initiatives in nutrition, epidemiology, and public health.

 

Research Interests

The candidate’s research interests focus on the intersection of nutrition, epidemiology, and public health, with a strong emphasis on understanding the role of diet in the prevention and development of chronic diseases, particularly type 1 diabetes and autoimmune conditions. They have led numerous large-scale, longitudinal studies that explore how dietary patterns, early nutrition, and environmental factors influence disease risk from childhood through adulthood. Their work aims to identify critical dietary determinants of health, unraveling complex interactions between genetics, immune response, and lifestyle factors. The candidate’s research also extends to nutritional epidemiology, investigating the impact of maternal and infant nutrition on long-term health outcomes. Through participation in international consortia and collaborations, they have contributed significantly to advancing scientific knowledge on immune-mediated diseases and dietary interventions. Their ultimate goal is to inform public health policies and develop evidence-based dietary guidelines that promote disease prevention and enhance the quality of life across populations.

 

Research Skills

The candidate demonstrates exceptional research skills characterized by a robust blend of scientific rigor, leadership, and multidisciplinary collaboration. As a Research Professor at the Finnish Institute for Health and Welfare, they lead innovative studies that address critical public health challenges, particularly in the fields of nutrition and epidemiology. Their expertise is further showcased by their involvement in international projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring initiatives, where they serve as a principal investigator. The candidate’s prolific publication record in high-impact journals underscores their ability to produce meaningful, data-driven insights that influence the scientific community and public health policies. They have consistently contributed to groundbreaking research on the relationship between diet and chronic diseases, including type 1 diabetes, through methodologically sound studies. Their ability to manage complex research projects and guide multidisciplinary teams highlights their outstanding research skills and commitment to advancing scientific knowledge for societal benefit.

 

Award And Recognition 

The candidate’s outstanding contributions to nutrition and epidemiological research have earned them significant recognition within the scientific community. As a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, they have led pioneering studies that address critical public health issues, including dietary impacts on autoimmune diseases. Their work has been published extensively in high-impact journals, and they are regularly invited to contribute to key international research collaborations, such as the EU-consortium Zero Hidden Hunger. They have played pivotal roles as principal investigator and committee member in numerous landmark studies, demonstrating exceptional leadership and expertise. The candidate’s dedication to advancing the fields of nutrition and public health has not only influenced policy but also improved health outcomes globally. Their achievements reflect a distinguished career marked by impactful research, academic leadership, and a commitment to enhancing the well-being of populations worldwide.

 

Conclusion

Based on the candidate’s comprehensive qualifications and achievements, they are highly deserving of the Best Researcher Award. With an extensive educational background that includes an MD and PhD from the University of Helsinki, the candidate has built a robust foundation in medical and research expertise. Their professional experience spans multiple high-impact roles, including Research Professor at the Finnish Institute for Health and Welfare and Professor of Epidemiology at Tampere University. They have demonstrated exceptional leadership in numerous significant research projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring programs. The candidate’s prolific publication record in top-tier journals, particularly on diet and autoimmune diseases like type 1 diabetes, highlights their contribution to advancing public health knowledge. Their multidisciplinary expertise, international collaborations, and commitment to impactful research establish them as a leading figure in their field, making them an outstanding candidate for this award.

 

Publication Top Notes

  1. Title: Early-pregnancy BMI, maternal gestational weight gain, and asthma and allergic diseases in children
    Authors: Ojwang’, V., Nwaru, B.I., Hanna-Mari, T., … Knip, M., Virtanen, S.M.
    Journal: Pediatric Allergy and Immunology
    Year: 2024
    Citations: 0
  2. Title: High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes—The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study
    Authors: Niinistö, S., Cuthbertson, D., Miettinen, M.E., … Savilahti, E., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  3. Title: Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child
    Authors: Hakola, L., Lund-Blix, N.A., Takkinen, H.-M., … Aki, S., Marja, R.
    Journal: Clinical Nutrition ESPEN
    Year: 2024
    Citations: 0
  4. Title: Gut Inflammation Markers, Diet, and Risk of Islet Autoimmunity in Finnish Children – A Nested Case-Control Study
    Authors: Salo, T.E., Hakola, L., Niinistö, S., … Knip, M., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  5. Title: Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk
    Authors: Bhosale, S.D., Moulder, R., Suomi, T., … Knip, M., Lahesmaa, R.
    Journal: iScience
    Year: 2024
    Citations: 0
  6. Title: Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study
    Authors: Hakola, L., Mramba, L.K., Uusitalo, U., … Norris, J.M., Virtanen, S.M.
    Journal: European Journal of Nutrition
    Year: 2024
    Citations: 1
  7. Title: Detecting potential outliers in longitudinal data with time-dependent covariates
    Authors: Mramba, L.K., Liu, X., Lynch, K.F., … Uusitalo, U.M., Krischer, J.P.
    Journal: European Journal of Clinical Nutrition
    Year: 2024
    Citations: 3
  8. Title: Fruit, berry, and vegetable consumption and the risk of islet autoimmunity and type 1 diabetes in children—the Type 1 Diabetes Prediction and Prevention birth cohort study
    Authors: Mattila, M., Takkinen, H.-M., Peltonen, E.J., … Knip, M., Virtanen, S.M.
    Journal: American Journal of Clinical Nutrition
    Year: 2024
    Citations: 1
  9. Title: How prices and income influence global patterns in saturated fat intake by age, sex and world region: a cross-sectional analysis of 160 countries
    Authors: Ahles, A., Muhammad, A., Yenerall, J.N., … Siamusantu, W., Brown, K.
    Journal: BMJ Open
    Year: 2024
    Citations: 0
  10. Title: Periodic mobile application (eMOM) with self-tracking of glucose and lifestyle improves treatment of diet-controlled gestational diabetes without human guidance: a randomized controlled trial
    Authors: Kytö, M., Hotta, S., Niinistö, S., … Heihonen, S., Koivusalo, S.B.
    Journal: American Journal of Obstetrics and Gynecology
    Year: 2024
    Citations: 0